No Data
No Data
Newly-Listed Psoriasis Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
Bio-Thera Biosimilar to J&J's Stelara Under FDA Review
Check Out What Whales Are Doing With JNJ
Johnson & Johnson (JNJ) Is Attracting Investor Attention: Here Is What You Should Know
Health Care Stocks Steady With Broader Market -- Health Care Roundup
Johnson & Johnson to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
muhamad Hazairudin s : Muhammad Hazairudin Shadan